The role of interferon-α as a modulator of fluorouracil and leucovorin
- 1 July 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (7-8) , 1316-1320
- https://doi.org/10.1016/0959-8049(95)91267-g
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Determinants of trimetrexate lethality in human colon cancer cellsBritish Journal of Cancer, 1994
- Influence of different doses of interferon-α-2b on the blood plasma levels of 5-fluorouracilEuropean Journal of Drug Metabolism and Pharmacokinetics, 1993
- Pharmacokinetics of 5-fluorouracil in colorectal cancer patients receiving interferonAnnals of Oncology, 1993
- Cytokines Induce Uridine Phosphorylase in Mouse Colon 26 Carcinoma Cells and Make the Cells More Susceptible to 5′‐Deoxy‐5‐fluorouridineJapanese Journal of Cancer Research, 1993
- Decreased Catabolism of Fluorouracil in Peripheral Blood Mononuclear Cells During Combination Therapy With Fluorouracil, Leucovorin, and Interferon -2aJNCI Journal of the National Cancer Institute, 1992
- Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cellsBiochemical and Biophysical Research Communications, 1992
- A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.Journal of Clinical Oncology, 1991
- Interaction Between 5-FluorouraciI, [6RS]Leucovorin, and Recombinant Human Interferon-α2a in Cultured Colon Adenocarcinoma CellsCancer Communications, 1991
- Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Interferon effects upon fluorouracil metabolism by HL-60 cellsBiochemical and Biophysical Research Communications, 1989